Could CAR-T treatments work in glioblastoma? – FierceBiotech
FierceBiotech |
Could CAR–T treatments work in glioblastoma?
FierceBiotech Penn scientists have spent the last two years exploring the potential of chimeric antigen receptor (CAR–T) cell therapy in glioblastoma. The technology, which is similar to the CAR-T treatment for blood cancer that Novartis has been developing with … |
